ScienceLife Sciences

The ReSViNET Podcast

The ReSViNET Foundation

The ReSViNET Podcast, by the ReSViNET Foundation, advances understanding of respiratory syncytial virus, RSV, through clear, evidence-based discussions. Designed for a broad audience, including healthcare professionals, researchers, and the wider community, it translates the latest science into practical insights. Topics include epidemiology, prevention, vaccination, long-term impact, and patient perspectives, with contributions from international experts to support informed decision-making.

Play

Open in

9 episodes
Avg 22 min
English

Episodes 9

Newest Oldest Longest

All9 Unplayed9 In progress0 Played0

S1 · E6
Thursday · 27 min
F is for Flu: How Do Influenza and RSV Interact? | The A-Z of RSV
RSV and influenza circulate across the world every year. But what happens when these two respiratory viruses meet at the population level? In this episode of The A–Z of RSV, host Marta Nunes speaks with mathematical modeller Matthieu Domenech de Celles about the relationship between influenza and RSV. They explore why RSV and influenza epidemics occur when they do, how population immunity, human behaviour and weather contribute to seasonality, and what emerging research tells us about interactions between the two viruses. Matthieu explains how mathematical modelling can help researchers investigate whether infection with one virus can temporarily influence susceptibility to another and how these interactions may shape epidemic patterns. The conversation also considers why these interactions could matter for surveillance, forecasting and prevention, and why studying respiratory viruses as part of an interconnected system may provide insights that cannot be gained by looking at each virus in isolation. The A–Z of RSV is a ReSViNET podcast series exploring RSV from A to Z with researchers, clinicians and experts from around the world. Stay up to date with the podcast series bysubscribing to the RSV newsletter: https://resvinet.org/sign-up-newsletter/ For more information about ReSViNET, go to www.resvinet.org. This podcast episode is supported by GSK. Guests on this podcast are invited for their expertise and experience. Any views, opinions, or interpretations expressed are those of the individual speakers and do not necessarily reflect the views, policies, or positions of the ReSViNET Foundation, the podcast producers, their employers, or any affiliated organisations. Discussions are intended to support education and informed debate based on current evidence and scientific understanding. The content is provided for informational and educational purposes only and should not be regarded as official guidance, organisational policy, or professional advice.
S1 · E5
October 22 · 29 min
E is for Evidence: RSV With and Without Testing | The A-Z of RSV
What is the role of diagnostic testing in RSV, and when can clinicians rely on clinical assessment alone? In this episode of The A–Z of RSV, host Natalie Mazur is joined by Ziyaad Dangor and Ashish Satav to explore how RSV is diagnosed across very different healthcare settings. From South Africa to rural India, they discuss what a clinical diagnosis of RSV looks like in practice, why access to diagnostic testing remains limited in many settings, and whether rapid RSV testing can change clinical decision-making. The conversation explores the challenges of distinguishing RSV from other respiratory illnesses, differences in diagnostic access and infrastructure, and the potential role of testing in antimicrobial stewardship, surveillance and infection control. The guests also consider why identifying RSV matters beyond the individual patient, including for understanding disease burden and supporting prevention and health policy. The A–Z of RSV is a ReSViNET podcast series exploring RSV from A to Z with researchers, clinicians and experts from around the world. Stay up to date with the podcast series by subscribing to the RSV newsletter: https://resvinet.org/sign-up-newsletter/ For more information about ReSViNET, go to www.resvinet.org. This podcast episode is supported by GSK. Guests on this podcast are invited for their expertise and experience. Any views, opinions, or interpretations expressed are those of the individual speakers and do not necessarily reflect the views, policies, or positions of the ReSViNET Foundation, the podcast producers, their employers, or any affiliated organisations. Discussions are intended to support education and informed debate based on current evidence and scientific understanding. The content is provided for informational and educational purposes only and should not be regarded as official guidance, organisational policy, or professional advice.
S2 · E4
October 20 · 27 min
D is for Diagnostics: How do we know when a respiratory infection is caused by RSV?
D is for Diagnostics How do we know when a respiratory infection is caused by RSV? And how has RSV testing changed over time? In this episode of The A–Z of RSV, host Lieke de Vrankrijker is joined by Professor Peter Richmond, paediatrician and paediatric immunologist from Perth, Australia, to explore the role of diagnostics in RSV. They discuss why RSV can be difficult to identify based on symptoms alone, how diagnostic testing has evolved from early laboratory methods to PCR and rapid tests, and how the COVID-19 pandemic changed respiratory virus testing. They also consider the role of testing in primary care and at home, and why accurate diagnosis is important for patient care, public health surveillance and understanding the impact of RSV prevention. The conversation also looks ahead to some of the remaining questions in RSV diagnostics, including how long people remain infectious and how clinicians can recognise secondary bacterial infections. The A–Z of RSV is a ReSViNET podcast series exploring RSV from A to Z with researchers, clinicians and experts from around the world. Stay up to date with the podcast series by subscribing to the RSV newsletter: https://resvinet.org/sign-up-newsletter/ For more information about ReSViNET, go to www.resvinet.org. This podcast episode is supported by GSK. Guests on this podcast are invited for their expertise and experience. Any views, opinions, or interpretations expressed are those of the individual speakers and do not necessarily reflect the views, policies, or positions of the ReSViNET Foundation, the podcast producers, their employers, or any affiliated organisations. Discussions are intended to support education and informed debate based on current evidence and scientific understanding. The content is provided for informational and educational purposes only and should not be regarded as official guidance, organisational policy, or professional advice.
September 22 · 40 sec
The A-Z of RSV Podcast Series
26 letters. 26 conversations. One virus. The A–Z of RSV is a podcast series exploring respiratory syncytial virus (RSV) from A to Z. In each episode, RSV experts explore a different topic, from the science behind the virus and its impact across different ages and populations, to prevention, research and the questions that still remain. Whether you work in RSV or simply want to understand more, join us as we explore RSV, one letter at a time.
S2 · E3
September 22 · 26 min
C is for Cardiology - Beyond the Lungs: RSV and Cardiovascular Risk
What does RSV have to do with the heart? In this episode of A–Z of RSV, host Marta Nunes is joined by Prof. Diederick E. Grobbee to explore C for Cardiology and the connection between RSV and cardiovascular disease. RSV is primarily known as a respiratory infection, but its impact may extend beyond the lungs. Together, Marta and Prof. Grobbee discuss why people with cardiovascular disease may be particularly vulnerable to RSV, and how an acute respiratory infection can place additional stress on an already vulnerable heart. RSV causes a respiratory infection, but in people with cardiovascular disease, such an infection can also affect the heart. People with cardiovascular disease may be particularly vulnerable to severe RSV disease, while the acute infection can, at the same time, place additional strain on an already vulnerable heart. They explore how cardiovascular disease can develop silently over time, how viral infections may act as acute triggers, why heart failure deserves particular attention, and what clinicians should know about the relationship between respiratory infections and cardiovascular health. The conversation also looks at what we still need to learn and why further research is important as new opportunities for RSV prevention become available. The A–Z of RSV is a ReSViNET podcast series exploring RSV from different perspectives, one letter at a time. This podcast is part of a ReSViNET educational project supported by GSK. Stay up to date with the podcast series by subscribing to the RSV newsletter: https://resvinet.org/sign-up-newsletter/ For more information about ReSViNET, visit: www.resvinet.org Guests on this podcast are invited for their expertise and experience. Any views, opinions, or interpretations expressed are those of the individual speakers and do not necessarily reflect the views, policies, or positions of the ReSViNET Foundation, the podcast producers, their employers, or any affiliated organisations. Discussions are intended to support education and informed debate based on current evidence and scientific understanding. The content is provided for informational and educational purposes only and should not be regarded as official guidance, organisational policy, or professional advice.
S2 · E2
September 16 · 21 min
B is for Burden: Understanding the True Impact of RSV | The A–Z of RSV
B is for Burden of Disease How large is the burden of RSV in infants who are otherwise healthy? In this episode of The A–Z of RSV, host Lieke de Vrankrijker is joined by paediatric infectious diseases specialist and researcher Joanne Wildenbeest to explore the burden of RSV disease, with a particular focus on healthy term-born infants. They discuss research showing that RSV burden extends beyond traditionally recognised high-risk groups, including the risk of hospitalisation among otherwise healthy infants and why the youngest babies are particularly vulnerable. The conversation also explores the wider burden of RSV infections managed outside the hospital, the influence of age and seasonality, healthcare-seeking by parents, and the association between RSV and subsequent wheezing. Looking ahead, Lieke and Joanne discuss how a better understanding of RSV burden can inform prevention and immunisation strategies, and what we still need to learn as RSV prevention is increasingly implemented. The A–Z of RSV is a ReSViNET podcast series exploring RSV from A to Z with researchers, clinicians and experts from around the world. Stay up to date with the podcast series by subscribing to the RSV newsletter: https://resvinet.org/sign-up-newsletter/ For more information about ReSViNET, visit: www.resvinet.org This podcast episode is supported by GSK. Guests on this podcast are invited for their expertise and experience. Any views, opinions, or interpretations expressed are those of the individual speakers and do not necessarily reflect the views, policies, or positions of the ReSViNET Foundation, the podcast producers, their employers, or any affiliated organisations. Discussions are intended to support education and informed debate based on current evidence and scientific understanding. The content is provided for informational and educational purposes only and should not be regarded as official guidance, organisational policy, or professional advice.
S2 · E1
September 7 · 22 min
A is for Asthma: What is the connection between RSV and asthma?
What do we know about the relationship between RSV infection early in life, recurrent wheezing and asthma later in childhood? In this episode of the A–Z of RSV podcast series, host Mauricio Caballero is joined by paediatric pulmonologist and researcher Prof. Renato Stein to explore the complex relationship between RSV and asthma. They discuss why wheezing in young children does not necessarily mean asthma, the different wheezing phenotypes seen in early childhood, and what research tells us about the association between severe RSV disease, subsequent wheezing and lung function. They also consider an important emerging question: could preventing severe RSV disease early in life reduce the risk or burden of recurrent wheezing later on? An insightful conversation about what we know, what remains uncertain, and why early-life respiratory infections matter for long-term respiratory health. Stay up to date with the podcast series by subscribing to the RSV newsletter you don’t want to miss: https://resvinet.org/sign-up-newsletter/ For more information about ReSViNET, go to www.resvinet.org. This podcast episode is supported by GSK. Guests on this podcast are invited for their expertise and experience. Any views, opinions, or interpretations expressed are those of the individual speakers and do not necessarily reflect the views, policies, or positions of the ReSViNET Foundation, the podcast producers, their employers, or any affiliated organisations. Discussions are intended to support education and informed debate based on current evidence and scientific understanding. The content is provided for informational and educational purposes only and should not be regarded as official guidance, organisational policy, or professional advice.
S1 · E2
June 10 · 33 min
Experiences from a general practitioner about RSV
In this podcast episode, pediatrician and infectious diseases specialist Lieke de Vrankrijker is in conversation with General Practitioner Albert J. van der Veer shares his knowledge and experiences with RSV.Recorded in 2024.
S1 · E1
June 10 · 17 min
Experiences from a gynaecologist about RSV
In this podcast episode, pediatrician and infectious diseases specialist Lieke de Vrankrijker is in conversation with Christine Brantner a gynaecologist who shares her knowledge and experiences with RSV.Recorded in 2024.

Showing 1–9 of 9 episodes